Dr. Hager Salem, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 120 N Commerce Ave, Front Royal, VA 22630 Phone: 540-635-0800 |
Dr. Thomas E Patteson Iii, M.D. Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 315 W 10th St, Front Royal, VA 22630 Phone: 540-635-0800 Fax: 540-635-0801 |
Amitkumar V Dave, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 N Shenandoah Ave, Front Royal, VA 22630 Phone: 843-237-3378 Fax: 843-237-5073 |
Dr. Patricia A Daly, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 315 W 10th St, Front Royal, VA 22630 Phone: 540-635-0800 Fax: 540-635-0801 |
Furadoon A Irani, M.D Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1000 N Shenandoah Ave, Front Royal, VA 22630 Phone: 540-636-0280 Fax: 540-636-0281 |
Rajdeep S Parmar, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 W Strasburg Rd, Front Royal, VA 22630 Phone: 800-969-1104 |
Guna Subedi, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 625 Virginia Ave, Front Royal, VA 22630 Phone: 540-635-7991 Fax: 540-636-2516 |
Dr. Meghan Danielle Gilleland Turner, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 120 N Commerce Ave Ste 255, Front Royal, VA 22630 Phone: 540-635-0800 Fax: 540-635-0801 |
Khalid Albedrani, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 625 Virginia Ave, Front Royal, VA 22630 Phone: 540-635-7991 |
Mawaddah Ahmed Mohamed Khalil Alislambouli, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 351 Valley Health Way, Warren Memorial Hospital, Front Royal, VA 22630 Phone: 615-371-5786 |
News Archive
Scientists have developed a new RNA interference therapeutic agent that safely blocked ocular inflammation in mice, potentially making it a new treatment for human uveitis and diabetic retinopathy.
Babies have a dark side under their cute exteriors, according to University of British Columbia-led study that finds infants as young as nine months embrace those who pick on individuals who are different from them.
Infinity Pharmaceuticals, Inc. today announced that it has initiated two Phase 1 clinical trials of IPI-145, a potent, orally available inhibitor of phosphoinositide-3-kinase (PI3K) delta and gamma. These two enzymes are implicated in hematologic cancers as well as a broad range of inflammatory conditions, which are the areas of focus within Infinity's PI3K clinical development program.
Most legal marijuana products supplied to medical dispensaries are stronger than recommended for treatment of chronic pain.
› Verified 3 days ago